{
    "ticker": "PRZO",
    "name": "Prozia, Inc.",
    "description": "Prozia, Inc. is an innovative biotechnology company focused on transforming the landscape of therapeutic solutions for chronic diseases. Founded in 2010, Prozia is dedicated to the research, development, and commercialization of advanced biologic treatments that leverage cutting-edge technologies to improve patient outcomes. The company's flagship product is a novel biologic therapy designed to target autoimmune disorders, aiming to provide more effective and safer alternatives to existing treatments. Prozia's research is driven by a commitment to understanding the underlying mechanisms of diseases and harnessing the power of biologics to address unmet medical needs. By collaborating with leading academic institutions and research organizations, Prozia is at the forefront of scientific advancements in immunology and regenerative medicine. The company\u2019s mission is to enhance the quality of life for patients through innovative therapies that are not only effective but also sustainable and accessible. As Prozia continues to expand its pipeline, it remains focused on its core values of integrity, excellence, and patient-centered care.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "San Diego, California, USA",
    "founded": "2010",
    "website": "https://www.prozia.com",
    "ceo": "Dr. Emily Roberts",
    "social_media": {
        "twitter": "https://twitter.com/ProziaInc",
        "linkedin": "https://www.linkedin.com/company/prozia-inc/"
    },
    "investor_relations": "https://ir.prozia.com",
    "key_executives": [
        {
            "name": "Dr. Emily Roberts",
            "position": "CEO"
        },
        {
            "name": "Mark Thompson",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Therapeutics",
            "products": [
                "Autoimmune Disorder Therapy",
                "Regenerative Medicine Solutions"
            ]
        }
    ],
    "seo": {
        "meta_title": "Prozia, Inc. | Innovative Biotherapeutics for Chronic Diseases",
        "meta_description": "Learn about Prozia, Inc., a biotechnology company dedicated to developing cutting-edge biologic therapies for chronic diseases. Explore our innovative solutions and commitment to improving patient care.",
        "keywords": [
            "Prozia",
            "Biotechnology",
            "Chronic Diseases",
            "Autoimmune Therapy",
            "Biologics"
        ]
    },
    "faq": [
        {
            "question": "What does Prozia specialize in?",
            "answer": "Prozia specializes in developing innovative biologic therapies for chronic diseases, particularly autoimmune disorders."
        },
        {
            "question": "Who is the CEO of Prozia?",
            "answer": "Dr. Emily Roberts is the CEO of Prozia, Inc."
        },
        {
            "question": "Where is Prozia headquartered?",
            "answer": "Prozia is headquartered in San Diego, California, USA."
        },
        {
            "question": "What are Prozia's main products?",
            "answer": "Prozia's main products include therapies for autoimmune disorders and regenerative medicine solutions."
        },
        {
            "question": "When was Prozia founded?",
            "answer": "Prozia was founded in 2010."
        }
    ],
    "competitors": [
        "AMGN",
        "REGN",
        "BIIB"
    ],
    "related_stocks": [
        "JNJ",
        "PFE",
        "MRK",
        "GILD"
    ]
}